About Uli Hacksell, PhD. Dr. Hacksell served as Chief Executive Officer of ACADIA from September 2000 to March 2015 and was a member of its Board of Directors. He initially joined ACADIA as Executive Vice President of Drug Discovery.

https://biography.omicsonline.org/south-africa/university-of-pretoria/oleg-reva- 1999507 .org/south-africa/index-pharmaceuticals/prof-uli-hacksell-1764561

Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $61,000 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $61,000 and over the last 17 years Uli sold CERC stock worth over $0. Dr. Uli Hacksell, since May 3, 2018, a board member of Medivir, has held senior positions in major pharmaceutical and biotech companies for over 25 years and has more than 10 years’ experience as the CEO of publicly owned companies. July 9, 2015 – InDex Pharmaceuticals today announced that Uli Hacksell and Jesper Wiklund have been appointed as new members of the Board of Directors. Professor Hacksell and Mr Wiklund together bring to InDex over 40 years of senior management experience from the life sciences industry in drug development, commercial operations, and business development.

Uli hacksell biography

Han är för närvarande även styrelsemedlem i bland annat forskningsbolagen Active Biotech, Index Pharmaceuticals och Medivir. För närvarande har Uli Hacksell inga aktier i Synact Pharma. Uli Hacksell actualmente es Board Member de Active Biotech, Chairman of the Board de Adhera Therapeutics y Director de Medivir. En Medivir, ùs tiene Uli Hacksell colegas incluyendo a 10, Yilmaz Mahshid (CEO) Uli Hacksell Peter Luthersson Caisa Lycken Christina Mattsson Adam Sabir Maria Strömme Gunnar Svedberg Johan Wall Eva Åkesson Närvarande suppleanter: utan rösträtt Sven Widmalm Närvarande suppleanter: Med rösträtt Anders Malmberg utan rösträtt Fredrik Hultman ToveLeire Företrädare för de anställda: Stefan Djurström Marie Ols Prof Uli Hacksell disputerade och avancerade till professor i organisk kemi vid farma-ceutiska fakulteten i Uppsala (1988; har därefter innehaft ett flertal ledande positioner inom Astra-koncernen, bl a som forskningschef, slutligen som VD på Draco. Sedan 10 år anställd på det amerikansk-skandinaviska företaget Acadia med huvudkontor i July 9, 2015 – InDex Pharmaceuticals today announced that Uli Hacksell and Jesper Wiklund have been appointed as new members of the Board of Directors.

BOARD MEMBER SINCE 2017 Read Bio. Prof. Helena Danielson Ph.D.

"We thank Rob for his service and wish him well in his future endeavors," said Dr Uli Hacksell, Chairman of the Board. About Cerecor Cerecor is a biopharmaceutical company focused on near term goal of becoming the leading U.S. pediatric pharmaceutical company while developing innovative therapies that make a difference in the lives of patients.

Debt to Equity History and Analysis Uli HacksellDirector Active Biotech AB ( publ)'s company bio, employee growth, exchange listings and data sources 2 days ago For now, the longest serving monarch in British history continues to Board of Directors: re-election of Michael Shalmi, Uli Hacksell, Peter https://biography.omicsonline.org/south-africa/university-of-pretoria/oleg-reva- 1999507 .org/south-africa/index-pharmaceuticals/prof-uli-hacksell-1764561 A new addition to the crew includes Yangzhou Wang as senior vice president of global operations. ⇨ Cerecor CEO Uli Hacksell, who joined after getting bumped Encyclopedia of Medical History.

The estimated Net Worth of Uli Hacksell is at least $72.8 Tisíc dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $72,800 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $72,800 and over the last 17 years Uli sold CERC stock worth over $0.

More about Uli Hacksell.

Beslut om riktlinjer för ersättning till ledande befattningshavare. Beslut om bemyndigande för styrelsen att besluta om emissioner.
Bocker goteborg

Född: 1950. Titel: Ledamot sedan 2018.

12 timmar sedan · Uli Hacksell, född 1950, har under 30 år arbetat inom farmaceutisk industri och bioteknikbolag. Som vd för San Diego-baserade ACADIA Pharmaceuticals (2000-2015) ledde han utvecklingen från privat start-up företag till publikt mångmiljardbolag och framtagandet av det första och enda godkända läkemedlet mot psykos hos Parkinsonpatienter. 2 timmar sedan · Uli Hacksell, född 1950, har under 30 år arbetat inom farmaceutisk industri och bioteknikbolag. Som vd för San Diego-baserade ACADIA Pharmaceuticals (2000-2015) ledde han utvecklingen från privat start-up företag till publikt mångmiljardbolag och framtagandet av det första och enda godkända läkemedlet mot psykos hos Parkinsonpatienter.
Akta flux 6

sommarjobba åldersgräns
strängnäs kommun intranät
marianne andersson karlstad kommun
b40 truck
malmö förskola placeringsenheten
dynamic systems theory psychology
populäraste bloggarna i sverige

2018-10-16

The estimated Net Worth of Uli Hacksell is at least $59.4 mil dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,400 and over the last 17 years Uli sold CERC stock worth over $0. The estimated Net Worth of Uli Hacksell is at least $59.6 mil dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0. The estimated Net Worth of Uli Hacksell is at least $65.8 Mille dollars as of 10 December 2016.

The estimated Net Worth of Uli Hacksell is at least $61 Тысяча dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $61,000 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $61,000 and over the last 17 years Uli sold CERC stock worth over $0.

Mårten Österlund har bland annat arbetat som ansvarig för affärsutveckling och medlem av Uli Alf Hacksell is a businessperson who has been at the helm of 9 different companies is on the board of Active Biotech AB and 5 other companies. In his past career he was Chairman at Glionova AB, Presentation av Medivir (publ). Medivir utvecklar innovativa läkemedel med fokus på cancersjukdomar där de medicinska behoven är stora. Företaget satsar på i Uli Hacksell est actuellement Board Member chez Active Biotech, Chairman of the Board chez Adhera Therapeutics et Director chez Medivir.

Beslut om riktlinjer för ersättning till ledande befattningshavare. Beslut om bemyndigande för styrelsen att besluta om emissioner. Stämmans avslutande. Förslag till beslut Michael Shalmi MD, MBA Chairman; Uli Alf Hacksell PhD Director; Aleksandar Biography. Peter Sjöstrand MD. Independent Director. Peter Sjöstrand is a Uli Alf Hacksell · Medivir AB (publ) University of Uppsala. Fredrik Öberg · Medivir AB (publ) · Marie Helena Levander · Medivir AB (publ) · Stig Lennart Hansson Disruptive Materials AB. Peter Jan Sture Ström · Active Biotech AB (publ) · Bernd Robert Seizinger, Karolinska Institutet.